Information:
Fel:
ID
14655
Beskrivning
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00219908
Länk
https://clinicaltrials.gov/show/NCT00219908
Nyckelord
Versioner (1)
- 2016-04-25 2016-04-25 -
Uppladdad den
25 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Relapsing-Remitting Multiple Sclerosis NCT00219908
Eligibility Relapsing-Remitting Multiple Sclerosis NCT00219908
- StudyEvent: Eligibility
Similar models
Eligibility Relapsing-Remitting Multiple Sclerosis NCT00219908
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
age : 18-45 years,
boolean
C0001779 (UMLS CUI [1])
Clinical disease
Item
clinical disease satisfying the poser criteria (amdmt n°4)
boolean
C0012634 (UMLS CUI [1])
Relapsing-Remitting Multiple Sclerosis
Item
relapsing-remitting disease (amdmt n°4)
boolean
C0751967 (UMLS CUI [1])
MS exacerbation
Item
at least 2 exacerbations within the preceding 12 months, having left sequelae,
boolean
C0581392 (UMLS CUI [1])
MRI with gadolinium
Item
mri activity at inclusion expressed by at least one gadolinium-enhanced lesion (cranial mri with 0.1mmol/kg gadolinium),
boolean
C0024485 (UMLS CUI [1,1])
C0016911 (UMLS CUI [1,2])
C0016911 (UMLS CUI [1,2])
EDSS score
Item
a significant disability at inclusion: edss score between 2.5 and 5.5 (amdt n° 4)
boolean
C0451246 (UMLS CUI [1])
Informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Gynaecological status
Item
pregnancy and breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Contraception
Item
use of an insufficiency effective contraceptive method,
boolean
C0700589 (UMLS CUI [1])
iImunosuppressive therapy
Item
general immunosuppressive therapy using cyclophosphamide, mitoxantrone,or total lymphoid irradiation
boolean
C0021079 (UMLS CUI [1])
Azathioprine
Item
treatment with azathioprine during the 3 months preceding the study
boolean
C0004482 (UMLS CUI [1])
Relapse and corticosteroid treatment
Item
clinical relapse or intensive corticosteroid treatment within the 30 days preceding inclusion,
boolean
C0277556 (UMLS CUI [1])
C0149783 (UMLS CUI [2])
C0149783 (UMLS CUI [2])
Comorbidity
Item
associated disease (psychiatric disorder, depressive statenot controlled by appropriate drug therapy, history of heart disease at inclusion examination
boolean
C0009488 (UMLS CUI [1])